GelStat Corporation
OTC: GSAC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Javier G. Acosta
- Employees
- 2
- Headquarters
- Palm City, United States
- IPO year
- 1996
- Market cap
- $123.6K
- Website
- https://www.gelstat.com
Loading GSAC…
Loading profile data…Frequently asked questions about GSAC
What does GelStat Corporation (GSAC) do?
GelStat Corporation operates as a consumer healthcare enterprise, specializing in the innovation, formulation, and commercialization of over-the-counter (OTC) and other non-prescription health solutions. Its diverse product portfolio addresses various common health concerns, featuring: GelStat Migraine, a patented remedy targeting migraine heada...
Where does GSAC trade?
GelStat Corporation (GSAC) trades on the Other OTC.
What sector is GSAC in?
GelStat Corporation (GSAC) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of GelStat Corporation?
Javier G. Acosta is the chief executive officer of GelStat Corporation (GSAC).
Where is GelStat Corporation headquartered?
GelStat Corporation is headquartered in United States.
Does GSAC pay a dividend?
GelStat Corporation (GSAC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GSAC go public?
GelStat Corporation (GSAC) completed its initial public offering in 1996.